Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $603,682 - $762,934
-2,546 Reduced 75.17%
841 $213,000
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $1.81 Million - $2.22 Million
-7,035 Reduced 67.5%
3,387 $994,000
Q4 2021

Feb 09, 2022

SELL
$292.08 - $329.01 $832,428 - $937,678
-2,850 Reduced 21.47%
10,422 $3.43 Million
Q3 2021

Nov 09, 2021

BUY
$272.21 - $332.43 $359,589 - $439,140
1,321 Added 11.05%
13,272 $4.04 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $1.45 Million - $1.75 Million
6,433 Added 116.58%
11,951 $3.21 Million
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $11,680 - $13,524
-55 Reduced 0.99%
5,518 $1.24 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $7,225 - $8,345
-34 Reduced 0.61%
5,573 $1.24 Million
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $36,317 - $44,142
-205 Reduced 3.53%
5,607 $1.21 Million
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $6,949 - $9,548
-54 Reduced 0.92%
5,812 $1.03 Million
Q1 2020

May 13, 2020

SELL
$121.39 - $169.05 $122,603 - $170,740
-1,010 Reduced 14.69%
5,866 $812,000
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $1,468 - $1,688
11 Added 0.16%
6,876 $1.06 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $7,040 - $7,616
-52 Reduced 0.75%
6,865 $992,000
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $41,085 - $47,287
-329 Reduced 4.54%
6,917 $989,000
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $393,342 - $454,262
4,147 Added 133.82%
7,246 $747,000
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $83,901 - $93,109
855 Added 38.1%
3,099 $337,000
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $191,323 - $212,327
2,244
2,244 $208,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $151B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track L & S Advisors Inc Portfolio

Follow L & S Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.